Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Romana Bútová"'
Publikováno v:
Non-Coding RNA, Vol 5, Iss 1, p 13 (2019)
Multiple myeloma (MM) is the second most common hematooncological disease of malignant plasma cells in the bone marrow. While new treatment brought unprecedented increase of survival of patients, MM pathogenesis is yet to be clarified. Increasing evi
Externí odkaz:
https://doaj.org/article/3f23956841b34f06be393ab74ba90efb
Autor:
Romana Bútová, Petra Vychytilová-Faltejsková, Jana Gregorová, Lenka Radová, Martina Almáši, Renata Bezděková, Lucie Brožová, Jiří Jarkovský, Zdeňka Knechtová, Martin Štork, Luděk Pour, Sabina Ševčíková
Publikováno v:
Biomedicines, Vol 9, Iss 11, p 1637 (2021)
Long non-coding RNAs (lncRNAs) are functional RNAs longer than 200 nucleotides. Due to modern genomic techniques, the involvement of lncRNAs in tumorigenesis has been revealed; however, information concerning lncRNA interplay in multiple myeloma (MM)
Externí odkaz:
https://doaj.org/article/f43e6c946a264e1f92f59c50de106207
Autor:
Martina Almáši, Lucie Brožová, Renata Bezděková, Lenka Radová, Jiří Jarkovský, Luděk Pour, Sabina Ševčíková, Zdeňka Knechtová, Jana Gregorová, Petra Vychytilova-Faltejskova, Romana Bútová, Martin Stork
Publikováno v:
Biomedicines
Volume 9
Issue 11
Biomedicines, Vol 9, Iss 1637, p 1637 (2021)
Volume 9
Issue 11
Biomedicines, Vol 9, Iss 1637, p 1637 (2021)
Long non-coding RNAs (lncRNAs) are functional RNAs longer than 200 nucleotides. Due to modern genomic techniques, the involvement of lncRNAs in tumorigenesis has been revealed
however, information concerning lncRNA interplay in multiple myeloma
however, information concerning lncRNA interplay in multiple myeloma
Publikováno v:
Non-Coding RNA
Non-Coding RNA, Vol 5, Iss 1, p 13 (2019)
Non-Coding RNA, Vol 5, Iss 1, p 13 (2019)
Multiple myeloma (MM) is the second most common hematooncological disease of malignant plasma cells in the bone marrow. While new treatment brought unprecedented increase of survival of patients, MM pathogenesis is yet to be clarified. Increasing evi
Autor:
Jiri Sana, Leos Kren, Natalia Anna Gablo, Marek Vecera, Pavol Mojak, Markéta Hermanová, Martin Smrčka, Štefan Reguli, Michal Filip, Radim Jančálek, Ondrej Slaby, Radim Lipina, Jaroslav Juracek, Romana Bútová, Tana Machackova
Publikováno v:
Cancer Research. 78:2459-2459
Introduction: Glioblastoma (GBM) is the most frequent primary brain tumor of astrocytic origin. The prognosis is unfavourable with the median overall survival (OS) being between 12 and 15 months from diagnosis. Identification of new therapeutic targe
Autor:
Kamila Souckova, Romana Bútová, Jaroslav Juracek, Parwez Ahmad, Martin Smrčka, Jiri Sana, Leos Kren, Tana Machackova, Natalia Anna Gablo, Marek Vecera, Ondrej Slaby, Radim Lipina
Publikováno v:
Cancer Research. 77:3445-3445
Introduction: Glioblastoma multiforme (GBM) is the most frequent primary brain tumor of astrocytic origin characterized by very poor prognosis. Despite conventional therapeutic protocol the prognosis of GBM patients is very poor with median of overal
Abstract 1959: Global microRNA expression analysis of Sox-2 positive and negative glioblastoma cells
Autor:
Robert Illiev, Romana Bútová, Jiri Sana, Marek Vecera, Pavel Fadrus, Jitka Mlcochova, Petra Vychytilová, Leos Kren, Jaroslav Juracek, Ondrej Slaby, Zuzana Ozanova
Publikováno v:
Cancer Research. 76:1959-1959
Introduction: Glioblastoma multiforme (GBM) is the most frequent intracranial malignity of astrocytic origin in adults. This tumor is characterized by infaust prognosis, which is primarily caused by resistance to the therapy and early relapses relate